All Relations between mog and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
I Tsunoda, L Q Kuang, D J Theil, R S Fujinam. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain pathology (Zurich, Switzerland). vol 10. issue 3. 2000-10-12. PMID:10885659. using an encephalitogenic peptide from myelin oligodendrocyte glycoprotein (mog)92-106, we have established animal models that mimic different forms of ms in 2 strains of h-2s mice, sjl/j and a.sw. 2000-10-12 2023-08-12 mouse
F D Shi, K Takeda, S Akira, N Sarvetnick, H G Ljunggre. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. Journal of immunology (Baltimore, Md. : 1950). vol 165. issue 6. 2000-10-10. PMID:10975822. myelin oligodendrocyte glycoprotein (mog) is a myelin component of the cns and is a candidate autoantigen in multiple sclerosis. 2000-10-10 2023-08-12 mouse
J B Rottman, A J Slavin, R Silva, H L Weiner, C G Gerard, W W Hancoc. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. European journal of immunology. vol 30. issue 8. 2000-09-22. PMID:10940928. after immunization with myelin oligodendrocyte glycoprotein (mog) 35-55 peptide, nearly all ccr1(+/+) mice developed eae (95% incidence, severity 2.5+/-0.1), whereas ccr1(-/-) mice had less severe disease (55% incidence, p<0.001; severity 1. 2000-09-22 2023-08-12 mouse
A Stefferl, A Schubart, M Storch2, A Amini, I Mather, H Lassmann, C Liningto. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). vol 165. issue 5. 2000-09-19. PMID:10946319. experimental autoimmune encephalomyelitis (eae) induced by sensitization with myelin oligodendrocyte glycoprotein (mog) is a t cell-dependent autoimmune disease that reproduces the inflammatory demyelinating pathology of multiple sclerosis. 2000-09-19 2023-08-12 rat
G Mancardi, B A Hart, E Capello, H P Brok, A Ben-Nun, L Roccatagliata, D Giunti, P Gazzola, M Dono, N Kerlero de Rosbo, M Colombo, A Uccell. Restricted immune responses lead to CNS demyelination and axonal damage. Journal of neuroimmunology. vol 107. issue 2. 2000-07-27. PMID:10854654. moreover, we report on the presence of inflammation, sharp demyelination and axonal damage in eae induced with whole myelin as well as with recombinant myelin oligodendrocyte glycoprotein (mog), but not with myelin basic protein alone. 2000-07-27 2023-08-12 Not clear
T Olsson, I Dahlman, E Wallström, R Weissert, F Pieh. Genetics of rat neuroinflammation. Journal of neuroimmunology. vol 107. issue 2. 2000-07-27. PMID:10854656. chronic relapsing experimental autoimmune encephalomyelitis (eae) with ms-like histopathology is achieved after immunization of certain rat strains with myelin oligodendrocyte glycoprotein (mog) or spinal cord homogenate. 2000-07-27 2023-08-12 human
E H Tran, W A Kuziel, T Owen. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. European journal of immunology. vol 30. issue 5. 2000-06-21. PMID:10820388. we examined the role of mip-1alpha and its ccr5 receptor in the induction of eae by immunizing c57bl / 6 mice deficient in either mip-1alpha or ccr5 with myelin oligodendrocyte glycoprotein (mog). 2000-06-21 2023-08-12 mouse
Y Okuda, S Sakoda, Y Saeki, T Kishimoto, T Yanagihar. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. Journal of neuroimmunology. vol 105. issue 2. 2000-05-25. PMID:10742553. to investigate the mechanism for the resistance of il-6-deficient mice to experimental autoimmune encephalomyelitis (eae), we examined the production of cytokines in lymph nodes (lns) of wild-type and il-6-deficient mice immunized with myelin oligodendrocyte glycoprotein (mog) by reverse transcriptase-polymerase chain reaction analysis. 2000-05-25 2023-08-12 mouse
S Issazadeh, K Abdallah, T Chitnis, A Chandraker, A D Wells, L A Turka, M H Sayegh, S J Khour. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. The Journal of clinical investigation. vol 105. issue 8. 2000-05-19. PMID:10772655. we found that mice transgenic for bcl-x(l) have an earlier onset and a more chronic form of eae induced by myelin oligodendrocyte glycoprotein (mog) peptide 35-55 compared with wild-type littermate mice. 2000-05-19 2023-08-12 mouse
J J Bajramović, A C Plomp, A v Goes, C Koevoets, J Newcombe, M L Cuzner, J M van Noor. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. Journal of immunology (Baltimore, Md. : 1950). vol 164. issue 8. 2000-05-09. PMID:10754336. in 3 of 10 active ms lesions, alpha b-crystallin could be detected inside phagocytic vesicles of perivascular macrophages, colocalizing with myelin basic protein and myelin oligodendrocyte glycoprotein (mog). 2000-05-09 2023-08-12 human
V H Secor, W E Secor, C A Gutekunst, M A Brow. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. The Journal of experimental medicine. vol 191. issue 5. 2000-04-04. PMID:10704463. using a myelin oligodendrocyte glycoprotein (mog)-induced model of acute eae, we show that mast cell-deficient w/w(v) mice exhibit significantly reduced disease incidence, delayed disease onset, and decreased mean clinical scores when compared with their wild-type congenic littermates. 2000-04-04 2023-08-12 mouse
F Mattner, S Smiroldo, F Galbiati, M Muller, P Di Lucia, P L Poliani, G Martino, P Panina-Bordignon, L Adorin. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). European journal of immunology. vol 30. issue 2. 2000-03-14. PMID:10671205. administration of 1,25(oh)(2)d(3) or its analogue prevents chronic-relapsing experimental allergic encephalomyelitis (cr-eae) induced by the myelin oligodendrocyte glycoprotein (mog) peptide 35 - 55 (mog(35 - 55)) in biozzi ab / h mice. 2000-03-14 2023-08-12 mouse
E Pál, T Yamamura, T Tabir. Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice. Journal of neuroimmunology. vol 100. issue 1-2. 2000-03-09. PMID:10695725. when actively sensitized with myelin oligodendrocyte glycoprotein (mog)35-55 peptide, control b6 mice developed a mild form of eae with full recovery. 2000-03-09 2023-08-12 mouse
G Wolswij. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain : a journal of neurology. vol 123 ( Pt 1). 2000-02-14. PMID:10611125. sections of post-mortem multiple sclerosis tissue were therefore immunolabelled with antibodies to galactocerebroside (galc), the first oligodendrocyte-specific molecule to be expressed by differentiating oligodendrocyte precursor cells, and myelin oligodendrocyte glycoprotein (mog), a marker for mature oligodendrocytes. 2000-02-14 2023-08-12 human
A M Butt, M Ibrahim, N Gregson, M Berr. Differential expression of the L- and S-isoforms of myelin associated glycoprotein (MAG) in oligodendrocyte unit phenotypes in the adult rat anterior medullary velum. Journal of neurocytology. vol 27. issue 4. 2000-02-08. PMID:10640185. in this study, we have determined the expression of myelin proteins in oligodendrocyte unit phenotypes i-iv, which myelinate fibres ranging in diameter from 0.3-12 microns diameter in the amv, by using double immunolabelling for rip, which labels entire units, and mbp, plp, myelin oligodendrocyte glycoprotein (mog), l-mag and s-mag. 2000-02-08 2023-08-12 rat
M Ichikawa, C S Koh, A Inoue, J Tsuyusaki, M Yamazaki, Y Inaba, Y Sekiguchi, M Itoh, H Yagita, A Komiyam. Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing--remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. Journal of neuroimmunology. vol 102. issue 1. 2000-02-03. PMID:10626667. treatment with monoclonal anti-il-12 antibody injected on day 0, 7 and 10 after immunization with myelin oligodendrocyte glycoprotein (mog) peptide 35-55 in nod mice resulted in significant suppression of the development and the severity of the chronic relapsing-remitting experimental autoimmune encephalomyelitis (eae) both clinically and histologically. 2000-02-03 2023-08-12 mouse
C Lucchinetti, W Brück, J Parisi, B Scheithauer, M Rodriguez, H Lassman. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain : a journal of neurology. vol 122 ( Pt 12). 2000-01-20. PMID:10581222. in inactive areas, an increased number of ogs expressing proteolipid protein (plp) mrna compared with those expressing myelin oligodendrocyte glycoprotein (mog) suggested these cells may have been derived from the progenitor pool. 2000-01-20 2023-08-12 Not clear
A E Juedes, P Hjelmström, C M Bergman, A L Neild, N H Ruddl. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). vol 164. issue 1. 2000-01-19. PMID:10605038. experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein (mog) in c57bl/6 (h-2b) mice is characterized by early (day 12) acute paralysis, followed by a sustained chronic clinical course that gradually stabilizes. 2000-01-19 2023-08-12 mouse
T W Spahn, S Issazadah, A J Salvin, H L Weine. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. European journal of immunology. vol 29. issue 12. 2000-01-04. PMID:10602017. immunization of c57bl / 6 mice with myelin oligodendrocyte glycoprotein (mog) peptide (p) 35 - 55 induces chronic experimental autoimmune encephalomyelitis (eae). 2000-01-04 2023-08-12 mouse
J A Lyons, M San, M P Happ, A H Cros. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. European journal of immunology. vol 29. issue 11. 1999-12-23. PMID:10556797. to further characterize the role of b cells in experimental allergic encephalomyelitis (eae), wild-type and b cell-deficient c57bl/6 mice were immunized with either a recombinant form of myelin oligodendrocyte glycoprotein (mog) or with the encephalitogenic mog(35-55) peptide. 1999-12-23 2023-08-12 mouse